Cath Booth

Cath Booth is the CEO of Epistem Ltd. since January 2000, having led the company through a management buyout from genedrive plc. Prior to this role, Cath Booth was the Founder and Director of Research Services and Founder and Managing Director of Contract Research Services at genedrive plc until June 2018, as well as an Executive Board Member. Cath Booth's early career includes a position as a Scientist at the Paterson Institute For Cancer Research from 1991 to 2001. Academically, Cath Booth earned a Ph.D. in Cell Biology from the University of Cambridge and a degree in Applied Biochemistry from Brunel University London.